Gene-expression signature predicts postoperative recurrence in stage I non-small cell lung cancer patients

PLoS ONE

Volumn 7, Issue 1, 2012, Pages

  Lu, Yan ^a   Wang, Liang ^b   Liu, Pengyuan ^a   Yang, Ping ^b   You, Ming ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; APOPTOSIS; AREA UNDER THE CURVE; ARTICLE; CANCER GROWTH; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; LEUKOCYTE ADHERENCE; LEUKOCYTE MIGRATION; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; POSTOPERATIVE PERIOD; PREDICTION; RECURRENCE FREE SURVIVAL; SCORING SYSTEM; SURVIVAL TIME; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION; TUMOR GENE; ADENOCARCINOMA; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; META ANALYSIS; PATHOLOGY; POSTOPERATIVE COMPLICATION; PROGNOSIS; RECURRENT DISEASE; TREATMENT OUTCOME; VALIDATION STUDY;

TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MALE; MICROARRAY ANALYSIS; NEOPLASM STAGING; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RECURRENCE; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 84856116589     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030880     Document Type: Article

References (28)

1. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
2. Flehinger BJ, Kimmel M, Melamed MR, (1992) The effect of surgical treatment on survival from early lung cancer. Implications for screening. Chest 101: 1013-1018.
3. Strauss GM, Kwiatkowski DJ, Harpole DH, Lynch TJ, Skarin AT, et al. (1995) Molecular and pathologic markers in stage I non-small-cell carcinoma of the lung. J Clin Oncol 13: 1265-1279.
4. Douillard JY, Rosell R, De Lena M, Carpagnano F, Ramlau R, et al. (2006) Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol 7: 719-727.
5. Le Chevalier T, Lynch T, (2004) Adjuvant treatment of lung cancer: current status and potential applications of new regimens. Lung Cancer 46 (Suppl 2): S33-39.
6. Winton T, Livingston R, Johnson D, Rigas J, Johnston M, et al. (2005) Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer. N Engl J Med 352: 2589-2597.
7. Strauss GM, Herndon JE 2nd, Maddaus MA, Johnstone DW, Johnson EA, et al. Randomized clinical trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in stage IB non-small cell lung cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633; 2004 Nov 1.
8. Strauss GM, Herndon JE, 2nd, Maddaus MA, Johnstone DW, Johnson EA, et al. (2008) Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol 26: 5043-5051.
9. Beer DG, Kardia SL, Huang CC, Giordano TJ, Levin AM, et al. (2002) Gene-expression profiles predict survival of patients with lung adenocarcinoma. Nat Med 8: 816-824.
10. Borczuk AC, Shah L, Pearson GD, Walter KL, Wang L, et al. (2004) Molecular signatures in biopsy specimens of lung cancer. Am J Respir Crit Care Med 170: 167-174.
11. Chen HY, Yu SL, Chen CH, Chang GC, Chen CY, et al. (2007) A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 356: 11-20.
12. Nielsen TO, West RB, Linn SC, Alter O, Knowling MA, et al. (2002) Molecular characterisation of soft tissue tumours: a gene expression study. Lancet 359: 1301-1307.
13. Sun Z, Yang P, Aubry MC, Kosari F, Endo C, et al. (2004) Can gene expression profiling predict survival for patients with squamous cell carcinoma of the lung? Mol Cancer 3: 35.
14. Wigle DA, Jurisica I, Radulovich N, Pintilie M, Rossant J, et al. (2002) Molecular profiling of non-small cell lung cancer and correlation with disease-free survival. Cancer Res 62: 3005-3008.
15. Lu Y, Lemon W, Liu PY, Yi Y, Morrison C, et al. (2006) A gene expression signature predicts survival of patients with stage I non-small cell lung cancer. PLoS Med 3: e467.
16. Buyse M, Burzykowski T, Michiels S, Carroll K, (2008) Individual- and trial-level surrogacy in colorectal cancer. Stat Methods Med Res 17: 467-475.
17. Shedden K, Taylor JM, Enkemann SA, Tsao MS, Yeatman TJ, et al. (2008) Gene expression-based survival prediction in lung adenocarcinoma: a multi-site, blinded validation study. Nat Med 14: 822-827.
18. Benito M, Parker J, Du Q, Wu J, Xiang D, et al. (2004) Adjustment of systematic microarray data biases. Bioinformatics 20: 105-114.
19. Li H, Gui J, (2004) Partial Cox regression analysis for high-dimensional microarray gene expression data. Bioinformatics 20 (Suppl 1): i208-215.
20. Akritas MG, (1994) Nearest neighbor estimation of a bivariate distribution under random censoring. Annu Stat 22.
21. Ichinose Y, Yano T, Yokoyama H, Inoue T, Asoh H, et al. (1994) Postrecurrent survival of patients with non-small-cell lung cancer undergoing a complete resection. J Thorac Cardiovasc Surg 108: 158-161.
22. Mao JH, Kim IJ, Wu D, Climent J, Kang HC, et al. (2008) FBXW7 targets mTOR for degradation and cooperates with PTEN in tumor suppression. Science 321: 1499-1502.
23. Iwatsuki M, Mimori K, Ishii H, Yokobori T, Takatsuno Y, et al. (2010) Loss of FBXW7, a cell cycle regulating gene, in colorectal cancer: clinical significance. Int J Cancer 126: 1828-1837.
24. Qiu H, Yashiro M, Zhang X, Miwa A, Hirakawa K, (2011) A FGFR2 inhibitor, Ki23057, enhances the chemosensitivity of drug-resistant gastric cancer cells. Cancer Lett 307: 47-52.
25. Fernandez-Borja M, van Buul JD, Hordijk PL, (2010) The regulation of leucocyte transendothelial migration by endothelial signalling events. Cardiovascular Research 86: 202-210.
26. Quigley RL, (1996) The effect of leukocytes on adhesion molecules. An explanation of blood transfusion enhancement of tumor growth. Arch Surg 131: 438-441.
27. Kim HS, Yi SY, Jun HJ, Ahn JS, Ahn MJ, et al. (2009) L1 cell adhesion molecule as a predictor for recurrence in pulmonary carcinoids and large-cell neuroendocrine tumors. APMIS 117: 140-146.
28. Tsai YC, Weissman AM, (2010) The Unfolded Protein Response, Degradation from Endoplasmic Reticulum and Cancer. Genes Cancer 1: 764-778.